Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
Director comp.
EXACT SCIENCES CORP (EXAS) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/09/2023 8-K Quarterly results
Docs: "Exact Sciences Announces First Quarter 2023 Results Reports record results, raises full-year guidance, accelerates path to positive free cash flow"
08/02/2022 8-K Quarterly results
Docs: "Exact Sciences Announces Second Quarter 2022 Results"
04/26/2022 8-K Quarterly results
Docs: "Exact Sciences announces first quarter 2022 results"
02/22/2022 8-K Quarterly results
11/02/2021 8-K Quarterly results
Docs: "Exact Sciences announces third quarter 2021 results"
07/28/2021 8-K Quarterly results
Docs: "Exact Sciences Announces Second Quarter 2021 Results"
05/04/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
10/27/2020 8-K Quarterly results
Docs: "Exact Sciences Announces Third Quarter 2020 Results"
07/30/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
10/29/2019 8-K Quarterly results
Docs: "Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million"
07/29/2019 8-K Quarterly results
04/30/2019 8-K Quarterly results
Docs: "First-quarter revenue and Cologuard test volume increased 79 percent to $162 million and 334,000, respectively"
10/30/2018 8-K Quarterly results
Docs: "Cologuard® revenue increased 63 percent to $118 million, and Cologuard test volume grew 49 percent to 241,000 during third quarter"
08/01/2018 8-K Quarterly results
Docs: "Cologuard® revenue increased 78 percent to $103 million during second quarter"
04/26/2018 8-K Quarterly results
Docs: "Cologuard® revenue and completed tests increased 87 percent to $90.3 million and 186,000"
10/30/2017 8-K Quarterly results
Docs: "Cologuard® revenue increased 158 percent to $73 million during third quarter Quarterly test volume grew 136 percent to 161,000 completed tests"
07/25/2017 8-K Form 8-K - Current report:
10/26/2016 8-K Form 8-K - Current report
07/26/2016 8-K Form 8-K - Current report
05/03/2016 8-K Form 8-K - Current report
10/29/2015 8-K Quarterly results
Docs: "Cologuard® Growth Trajectory Increases to 34,000 Completed Tests, Generates $12.6M in Revenue in Third Quarter 2015"
07/20/2015 8-K Quarterly results
Docs: "Exact Sciences Highlights Cologuard's® Positive Launch Trajectory in Second Quarter 2015"
05/04/2015 8-K Quarterly results
Docs: "Exact Sciences Reports Strong Growth Trajectory for Cologuard™ in First-Quarter 2015 MADISON, Wis."
10/27/2014 8-K Quarterly results
Docs: "Exact Sciences reports third-quarter 2014 financial results MADISON, Wis."
07/22/2014 8-K Quarterly results
Docs: "Exact Sciences reports second-quarter 2014 financial results MADISON, Wis."
05/01/2014 8-K Quarterly results
Docs: "Exact Sciences reports first-quarter 2014 financial results MADISON, Wis."
10/29/2013 8-K Form 8-K - Current report
07/23/2013 8-K Quarterly results
Docs: "Exact Sciences reports second-quarter 2013 financial results MADISON, Wis."
05/01/2013 8-K Quarterly results
Docs: "Exact Sciences reports first-quarter 2013 financial results, announces addition to board of directors MADISON, Wis."
10/30/2012 8-K Form 8-K - Current report
07/25/2012 8-K Form 8-K - Current report
05/01/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy